Insider Sellers Might Regret Selling Tevogen Bio Holdings Shares at a Lower Price Than Current Market Value

Even though Tevogen Bio Holdings Inc. (NASDAQ:TVGN) has fallen by 15% over the past week , insiders who sold US$2.5m worth of stock over the past year have had less luck. Insiders would probably have been better off holding on to their shares given that the average selling price of US$1.19 is still lower than the current share price.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

The Last 12 Months Of Insider Transactions At Tevogen Bio Holdings

In the last twelve months, the biggest single sale by an insider was when the Co-Founder, Ryan Saadi, sold US$1.8m worth of shares at a price of US$1.23 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$0.47. So it is hard to draw any strong conclusion from it.

In the last year Tevogen Bio Holdings insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

See our latest analysis for Tevogen Bio Holdings

I will like Tevogen Bio Holdings better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Does Tevogen Bio Holdings Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Tevogen Bio Holdings insiders own 89% of the company, currently worth about US$84m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Do The Tevogen Bio Holdings Insider Transactions Indicate?

It doesn't really mean much that no insider has traded Tevogen Bio Holdings shares in the last quarter. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Tevogen Bio Holdings insiders selling. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Every company has risks, and we've spotted 4 warning signs for Tevogen Bio Holdings (of which 2 don't sit too well with us!) you should know about.

Of course Tevogen Bio Holdings may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.